What Is GHRP-6?
Growth Hormone–Releasing Peptide-6 (GHRP-6) is a laboratory-synthesized ghrelin receptor agonist used to stimulate endogenous growth hormone secretion. As part of a small group of ghrelin analogues, it has been studied for its influence on cardiovascular cells, cognitive processes, wound healing mechanisms, sexual behavior, and neuronal survival in Parkinson’s disease research. The peptide is orally and sublingually active and shows moderate to high receptor specificity in experimental systems.
GHRP-6 Structure
GHRP-6 is composed of a compact peptide chain designed to interact selectively with ghrelin receptors. Its molecular configuration supports functional stability and reproducible biological activity during laboratory investigation.
GHRP-6 Effects
1. Cognitive Retention and Learning
Experimental research indicates that ghrelin signaling contributes to learning efficiency and memory retention. GHRP-6 has been shown to enhance consolidation of newly formed memories and improve performance in spatial learning tasks in animal models.
2. Central Nervous System Protection
Stroke-related studies demonstrate that GHRP-6 limits neuronal damage during ischemic events. Timely administration has been associated with reduced cognitive impairment following stroke, likely through suppression of apoptotic and inflammatory pathways.
3. Parkinson’s Disease–Related Neuronal Support
Preclinical studies show reduced ghrelin receptor expression in dopaminergic neurons affected by Parkinson’s pathology. GHRP-6 may reduce neuronal loss by activating remaining receptors and limiting programmed cell death in the substantia nigra.
4. Skin Repair and Scar Reduction
Animal research indicates that GHRP-6 accelerates wound healing by promoting angiogenesis and extracellular matrix formation. These effects contribute to faster wound closure, improved tissue strength, and reduced hypertrophic scar formation.
5. Cardioprotective Properties
In models of acute myocardial infarction, GHRP-6 has been shown to reduce oxidative injury during reperfusion. Preservation of cardiac tissue may improve experimental recovery outcomes.
6. Motivation and Mood Regulation
Activation of ghrelin receptors in the brain has been linked to motivation and reward processing. GHRP-6 demonstrates effects on sexual motivation and has been examined for potential influence on mood-related neural pathways.
Research Use Disclaimer
Animal studies report acceptable tolerability and bioavailability; however, these findings are not applicable to humans. GHRP-6 is intended solely for laboratory research and educational purposes.
Authorship and Scientific Acknowledgment
This summary credits the scientific work of Dr. Logan, M.D., and Professor Marta Korbonits. References are included for scholarly attribution only.
Resourced Citations
- C.-C. Huang, D. Chou, C.-M. Yeh, and K.-S. Hsu, "Acute food deprivation enhances fear extinction but inhibits long-term depression in the lateral amygdala via ghrelin signaling," Neuropharmacology, vol. 101, pp. 36–45, Feb. 2016.
- S. Beheshti and S. Shahrokhi, "Blocking the ghrelin receptor type 1a in the rat brain impairs memory encoding," Neuropeptides, vol. 52, pp. 97–102, Aug. 2015.
- K. Tóth, K. Laszlo, and L. Lenard, "Role of intraamygdaloid acylated-ghrelin in spatial learning," Brain Res. Bull., vol. 81, no. 1, pp. 33–37, Jan. 2010.
- N. Sucháč et al., "Assessment of dose-effect and therapeutic time window in preclinical studies of nIGF-1 and GHRP-6 coadministration for stroke therapy," Neurol. Res., vol. 38, no. 3, pp. 187–195, Mar. 2016.
- S. J. Spencer, A. A. Miller, and Z. B. Andrews, "The Role of Ghrelin in Neuroprotection after Ischemic Brain Injury," Brain Sci., vol. 3, no. 1, pp. 344–359, Mar. 2013.
- Y. Sutra et al., "Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction," Mol. Brain., vol. 11, no. 1, p. 6, 25 2018.
- Y. Mendoza-Mari et al., "Growth Hormone-Releasing Peptide-6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wound Plastic Surgery. International, 2016. [Online]. Available: https://www.hindawi.com/journals/jps/2016/4361702/. [Accessed: 23 May 2019].
- M. Fernández-Mayola et al., "Growth hormone releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study," Int. Wound J., vol. 15, no. 4, pp. 538–546, Aug. 2018.
- J. Berlanga et al., "Growth hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction," Clin. Sci. Lond. Engl. 1979, vol. 112, no. 4, pp. 241–250, Feb. 2007.
- L. Hyland et al., "Central ghrelin receptor stimulation modulates sex motivation in male rats in a site dependent manner," Horm. Behav., vol. 97, pp. 56–66, 2018.
- H. J. Huang et al., "The protective effects of Ghrelin/GHSR on hippocampal neurogenesis in CUMS mice," Neuropharmacology, May 2019.
- Korbonits, Marta, and Ashley B. Grossman. "Growth Hormone-Releasing Peptide and Its Analogues." Trends in Endocrinology & Metabolism, vol. 6, no. 2, Mar. 1995, pp. 43–49.